On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Bringing Effective Solutions to Vast Market

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is engaged in establishing a new standard for the visualization of cancer during minimally invasive surgeries (“MIS”). The company is currently focused on bladder cancer, the most expensive cancer to treat due to a high 50% recurrence rate that leaves approximately 600,000 U.S. patients living … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Bringing Effective Solutions to Vast Market”

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reimagines Technology to Create Better Cancer Outcomes

Archaic technology contributes to dismal recurrence rate in bladder cancer Imagin Medical revolutionizes the way surgeons can visualize cancer to better identify, and remove during surgery There is potential to extend this technology to virtually other endoscopic procedures The battle against cancer is too often set back by crushing blows of recurrence. The disease is … Continue reading “Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reimagines Technology to Create Better Cancer Outcomes”

Better Cancer Outcomes Possible with Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology

Imagin Medical Inc.’s patented i/Blue System revolutionizes the way surgeons are able to visualize the bladder and identify cancers during surgery The breakthrough technology of Imagin Medical’s i/Blue Imaging System rectifies the limitations of both white and blue light cystoscopies Bladder cystoscopies first target – multiple other endoscopic procedures planned Science and technology have continued … Continue reading “Better Cancer Outcomes Possible with Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology”

NetworkNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) i/Blue Imaging(TM) Technology Holds Potential Across Multiple Endoscopic Procedures

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is focused on changing the standards of visualizing cancer during minimally invasive procedures. The company’s innovative technology has the potential to revolutionize the current standard of care for bladder cancer patients. Imagin Medical’s i/Blue Imaging(TM) System is based on advanced optics and light sensors and … Continue reading “NetworkNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) i/Blue Imaging(TM) Technology Holds Potential Across Multiple Endoscopic Procedures”

Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech

Imagin Medical Inc. announced that it has now raised $2.165 million of the recent its convertible note offering The closing of the latest funding tranche will support the company’s progress toward the commercialization of its revolutionary bladder cancer visualization technology once final FDA approval is granted With better viewing options, the technology is designed to … Continue reading “Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech”

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTC: IMEXF) Announces Closing of 2nd Tranche of Convertible Note Offering

Imagin Medical (CSE: IME) (OTC: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced that, further to its press releases of Oct. 22 and Nov. 10, 2020, it has closed the second tranche in the amount of US$1,415,500 of the convertible note … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTC: IMEXF) Announces Closing of 2nd Tranche of Convertible Note Offering”

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Improving the Odds in Fighting Bladder Cancers

Imagin Medical Inc. is a surgical imaging company helping to advance the use of blue light cystoscopy (“BLC”) in battling bladder cancer and reducing costs associated with these procedures Bladder cancer is the sixth most prevalent cancer in the United States, and the third most common in men, yet the most expensive to treat While … Continue reading “Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Improving the Odds in Fighting Bladder Cancers”

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021”

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence

The current standard for bladder cancer visualization, white light, is over three decades old and used in 95% of the bladder cancer surgeries The recurrence rate of bladder cancer is more than 50% due to the inability to see clear margins in the white light surgical standard for visualization Imagin Medical Inc.’s proprietary i/Blue(TM) System … Continue reading “Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence”

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Harnesses Blue Light, Innovative Technology for Cancer Imaging

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is harnessing the virtues of blue light in a health-enhancing way. By utilizing the company’s proprietary i/Blue Imaging (TM) System with a contrast agent, surgeons will be able to better visualize the parameters of cancers and develop the appropriate response strategy. Imagin is developing its … Continue reading “NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Harnesses Blue Light, Innovative Technology for Cancer Imaging”

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217